Welcia Holdings Co., Ltd. (TYO:3141)
Japan
· Delayed Price · Currency is JPY 2,475.00
-38.00 (-1.51%)
May 13, 2025, 3:30 PM JST
Welcia Holdings Revenue
In the fiscal year ending February 28, 2025, Welcia Holdings had annual revenue of 1.29T JPY with 5.56% growth. Welcia Holdings had revenue of 327.21B in the quarter ending February 28, 2025, with 6.63% growth.
Revenue
1,285.01B
Revenue Growth
+5.56%
P/S Ratio
0.40
Revenue / Employee
84.06M
Employees
15,286
Market Cap
513.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1,285.01B | 67.67B | 5.56% |
| Feb 29, 2024 | 1,217.34B | 73.06B | 6.38% |
| Feb 28, 2023 | 1,144.28B | 118.33B | 11.53% |
| Feb 28, 2022 | 1,025.95B | 76.30B | 8.03% |
| Feb 28, 2021 | 949.65B | 81.37B | 9.37% |
| Feb 29, 2020 | Pro | Pro | Pro |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |